MedKoo Cat#: 130248 | Name: ENT-01

Description:

WARNING: This product is for research use only, not for human or veterinary use.

ENT-01 shows promise in the treatment of constipation in those with Parkinson's disease (PD) by preventing or reducing the formation of αS aggregates that form in enteric neurons. ENT-01 has undergone Phase 2b clinical trials to evaluate the safety and efficacy of the orally administered drug for the alleviation of constipation in those with PD.

Chemical Structure

ENT-01
ENT-01
CAS#N/A

Theoretical Analysis

MedKoo Cat#: 130248

Name: ENT-01

CAS#: N/A

Chemical Formula: C34H65N3O5S

Exact Mass: 627.4645

Molecular Weight: 627.97

Elemental Analysis: C, 65.03; H, 10.43; N, 6.69; O, 12.74; S, 5.11

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
ENT-01; ENT01; ENT 01
IUPAC/Chemical Name
(3R,6R)-6-((3S,5R,7R,9S,10S,13R,14S,17R)-3-((3-((4-aminobutyl)amino)propyl)amino)-7-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methylheptan-3-yl hydrogen sulfate
InChi Key
UIRKNQLZZXALBI-XJTYUZMVSA-N
InChi Code
InChI=1S/C34H65N3O5S/c1-23(2)31(42-43(39,40)41)12-9-24(3)27-10-11-28-32-29(14-16-34(27,28)5)33(4)15-13-26(21-25(33)22-30(32)38)37-20-8-19-36-18-7-6-17-35/h23-32,36-38H,6-22,35H2,1-5H3,(H,39,40,41)/t24-,25-,26+,27-,28+,29+,30-,31-,32?,33+,34-/m1/s1
SMILES Code
O=S(O)(O[C@H](CC[C@H]([C@H]1CC[C@@]2([H])C3[C@H](O)C[C@@]4([H])C[C@@H](NCCCNCCCCN)CC[C@]4(C)[C@@]3([H])CC[C@]12C)C)C(C)C)=O
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 627.97 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1. Camilleri M, Subramanian T, Pagan F, Isaacson S, Gil R, Hauser RA, Feldman M, Goldstein M, Kumar R, Truong D, Chhabria N, Walter BL, Eskenazi J, Riesenberg R, Burdick D, Tse W, Molho E, Robottom B, Bhatia P, Kadimi S, Klos K, Shprecher D, Marquez-Mendoza O, Hidalgo G, Grill S, Li G, Mandell H, Hughes M, Stephenson S, Vandersluis J, Pfeffer M, Duker A, Shivkumar V, Kinney W, MacDougall J, Zasloff M, Barbut D. Oral ENT-01 Targets Enteric Neurons to Treat Constipation in Parkinson Disease : A Randomized Controlled Trial. Ann Intern Med. 2022 Dec;175(12):1666-1674. doi: 10.7326/M22-1438. Epub 2022 Nov 8. Erratum in: Ann Intern Med. 2023 Jan;176(1):144. PMID: 36343348. 2. Correction: Oral ENT-01 Targets Enteric Neurons to Treat Constipation in Parkinson Disease. Ann Intern Med. 2023 Jan;176(1):144. doi: 10.7326/L22-0464. Epub 2022 Dec 20. Erratum for: Ann Intern Med. 2022 Dec;175(12):1666-1674. PMID: 36598175. 3. https://www.nature.com/articles/d43747-020-00717-w